Acceptability in Dialogues With the Robot EBO

December 15, 2022 updated by: Elisa María Garrido Ardila, University of Extremadura

Acceptability in Dialogues Between the Robot EBO and Older Adults

This is a descriptive observational study (first results cross-sectional study, second results longitudinal study). The participants of the study will be exposed to a dialogue with the robot EBO. The user and the therapist's acceptability of the robot, the robot-user interaction during the conversation and the conversation parameters will be assessed.

Study Overview

Status

Completed

Detailed Description

This is a descriptive observational study (first results cross-sectional study, second results longitudinal study). The participants of the study will be exposed to a dialogue with the robot EBO. The user and the therapist's acceptability of the robot will be measure. Also the robot-user interaction during the conversation and the conversation parameters will be assessed. The assessements will be done at week 0 and at week 3. During weeks 1 and 2 the robot will be present in the therapeutic activities of the center.

Study Type

Observational

Enrollment (Actual)

6

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cáceres, Spain, 10003
        • University of Extremadura

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The population of study will be patients with neurological disorders who receive rehabilitation treatment in socio-health centers in Extremadura (Spain).

Description

Inclusion Criteria:

  • Users of socio-health centers in Extremadura (Spain).
  • Patients with neurological pathology diagnosed by a specialist doctor.
  • Over 65 years of age
  • Minimental State Examination with a score greater than or equal to 21 (mild-moderate cognitive impairment).

Exclusion Criteria:

  • Severe cognitive impairment
  • Language impairment that prevents the use of verbal communication.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Robot interaction

EBO is a robotic platform consisting of the following: A screen display capable of generating emotions (sadness, joy, neutral, anger, disgust and surprise), RGB camera, basic navigation system.

EBO must be controlled by a teleoperator through a user-friendly and simple interface. Communication should be as immediate as possible, as well as predefined. In any case, the dialogue flow can be modified if necessary. The interface, at the same time, allows the possibility of sending emotions and small movements to the robot, to accompany the dialogue with certain elements of emotionality.

The experiment replicates the Wizard of Oz technique. In this technique, the human tele-operator controls the robot without the person noticing it as he is in another room. For this purpose, a user interface will be displayed on the teleoperator's terminal and the commands will be reproduced by the EBO robot

The participants will interact with the Robot EBO. The robot will be control by an operator that will conduct a dialogue. The dialogue will include questions related to the social, leisure, activities of daily living and informative areas.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Robot-user interaction during the conversation: Conversation topic that most motivates the user or with which the user most interacts with the robot measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Robot-user interaction during the conversation measured by recording and viewing the conversation
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Robot-user interaction during the conversation: attempts to touch the robot by the patient measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Robot-user interaction during the conversation measured by recording and viewing the conversation
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Robot-user interaction during the conversation: times the user asks the robot questions measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Robot-user interaction during the conversation measured by recording and viewing the conversation.
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Robot-user interaction during the conversation: emotions that the conversation provokes in the patient measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Robot-user interaction during the conversation measured by recording and viewing the conversation: emotions that the conversation provokes in the user (Standard, happy, sad, angry)
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Robot-user interaction during the conversation: number of total interactions measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Robot-user interaction during the conversation measured by recording and viewing the conversation.
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Conversation parameters: time of the dialogue measured by the robot's register
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Conversation parameters measured by the robot's register
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Conversation parameters: speed of response measured by the robot's register
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Conversation parameters (measured by the robot's register): speed of response (time taken by the patient to respond)
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Conversation parameters: eye contact and patient's attention measured by the robot's register
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Conversation parameters (measured by the robot's register): eye contact with the robot and the attention of the patient to follow the conversation.
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Conversation parameters: repetition of questions measured by the robot's register
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
Conversation parameters (measured by the robot's register): number of times the patient needed to be asked a question again.
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
User acceptability of the robot with the Technology Acceptance Model questionnaire
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention

User acceptability of the robot measured with the Technology Acceptance Model. This scale has good validity and reliability, with a Cronbach's alpha value above 0.8 (Alenazy, Mugahed Al-Rahmi, & Khan, 2019). It assesses the following dimensions relating to the technology product:

  • Perceived ease of use: the extent to which users believe that using a particular system would improve their performance.
  • Perceived usefulness: the extent to which the individual believes that using the system will be effortless
  • Attitude towards use
  • Relevance

A higher scores indicates a higher acceptability.

Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
User acceptability of the robot measures with an specific designed questionnaire
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
User acceptability of the robot measured with a questionnaire designed by the authors of the study. The questionnaire has 10 items that evaluate the acceptability of the robot by the user. This 10 questions have 3 choice answer with the options being yes, no, I don not know. There is one open question to collect qualitative data a¡regarding the dialogue and the acceptability.
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2021

Primary Completion (Actual)

January 30, 2022

Study Completion (Actual)

April 30, 2022

Study Registration Dates

First Submitted

May 2, 2021

First Submitted That Met QC Criteria

May 14, 2021

First Posted (Actual)

May 21, 2021

Study Record Updates

Last Update Posted (Actual)

December 16, 2022

Last Update Submitted That Met QC Criteria

December 15, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 128/2018

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nervous System Diseases

Clinical Trials on Interaction and exposure with the Robot EBO

Subscribe